
6/17/2019
WHAT: UPMC Hillman Cancer Center, the UPMC Adult Sickle Cell Disease Program and UPMC Children’s Hospital of Pittsburgh will host a Family Sickle Cell Research Summit to highlight new treatment options at UPMC which have reversed sickle cell disease. Stem cell transplants have been effective in treating sickle cell disease in children, but, until now, have been too toxic to treat severe disease in adults. Now, UPMC researchers say clinical trials, using a modified stem cell transplant, have proven successful in these adult patients.

WHO:
- Gregory J. Kato, M.D., professor of medicine in hematology/oncology, University of Pittsburgh School of Medicine and director of the Sickle Cell Center of Excellence at Pitt and UPMC
- Michael L. Matthews, executive director, Children’s Sickle Cell Foundation, Inc.
- Sickle cell patients
- UPMC sickle cell researchers and physicians
WHERE: UPMC Montefiore Hospital, LHAS Auditorium 3459 Fifth Ave., Pittsburgh, 15213.
WHEN: 2:00 to 6 p.m., Wednesday, June 19
Note to Media: To cover this event, arrangements must be made in advance by contacting Cyndy Patton at 412-415-6085 or PattonC4@upmc.edu.
IMAGE INFO:
CREDIT: Healthwise 2018